Johnson & Johnson launches website for direct-to-consumer sales

Core Insights - Johnson & Johnson has launched a direct-to-consumer website named J&J Direct to sell certain medications directly to U.S. patients without insurance or those paying out of pocket [1] - The website currently lists three drugs: diabetes treatments Invokana and Invokamet, and blood thinner Xarelto [1] - This initiative is part of a broader commitment by the company to enhance access to its drugs, following an agreement with the Trump administration aimed at reducing drug prices [1] Business - The company has pledged to invest $55 billion in the U.S. over four years as part of its strategy to improve drug accessibility [1] - Johnson & Johnson is among several pharmaceutical companies, including Pfizer and Eli Lilly, that have initiated direct-to-consumer sales platforms [1] - The U.S. government has also launched TrumpRx.gov, a website offering discounted prescription medicines, although Johnson & Johnson is not currently selling on this platform [1]